HRs for drug discontinuation, higher preference versus lower preference
| HR (95% CI) | |||
|---|---|---|---|
| Approach | Preference threshold 60% | Preference threshold 70% | Preference threshold 80% |
| Patients with higher preference, N (%) | 1426 (52) | 1234 (45) | 987 (36) |
| Non-clustered data analysis | |||
| Crude | 0.88 (0.79 to 0.98) | 0.89 (0.80 to 0.99) | 0.83 (0.81 to 0.996) |
| Adjusted* | 0.86 (0.76 to 0.98) | 0.88 (0.77 to 1.01) | 0.87 (0.75 to 1.004) |
| Marginal modelling of clustered data | |||
| Crude | 0.88 (0.77 to 1.001) | 0.89 (0.78 to 1.01) | 0.89 (0.79 to 1.01) |
| Adjusted† | 0.85 (0.76 to 0.96) | 0.87 (0.78 to 0.97) | 0.87 (0.78 to 0.98) |
Percent from overall patients (2742).
*Adjusted by drug, calendar year, patient's demographics and clinical status, and prescriber.
†Adjusted by drug, calendar year, and patient's demographics and clinical status.